Pneumococcal Conjugate Vaccine Surveillance and Evaluation in Burkina Faso

Program Description: To support the introduction of a change in Burkina Faso’s infant pneumococcal vaccine schedule to include a booster dose and to evaluate the impact of the country’s capacity to control pneumococcal disease among children and adults.
Funding Partners:
  • Bill & Melinda Gates Foundation
Program Partners:
  • CDC's National Center for Immunization and Respiratory Diseases
Program Location:
  • Burkina Faso
Viral Diseases
Infectious Disease
Vaccines